Literature DB >> 6257892

Multiple benzodiazepine receptor localization by light microscopic radiohistochemistry.

W S Young, D Niehoff, M J Kuhar, B Beer, A S Lippa.   

Abstract

Benzodiazepine receptor binding studies have been reported suggesting the existence of at least two different benzodiazepine receptors. One distinguishing feature of these two sites is that one has a high affinity for triazolopyridazines, whereas the other has a low affinity. In this study, the regional localization of the two different receptors was examined by light microscopic radiohistochemical methods. [3H]Flunitrazepam was used to label all types of benzodiazepine receptors in slide-mounted tissue sections. CL218,872, a typical triazolopyridazine, was used to preferentially displace [3H]flunitrazepam from the subclass of receptors having a high affinity for CL218,872. Autoradiographs clearly showed that receptor binding in some regions was substantially affected by CL218,872 while that in other regions was affected to a lesser degree. Areas with receptors with high affinity for the triazolopyridazine (Type 1 receptors) included the cerebellum, globus pallidus and parts of the cerebral cortex. Areas with receptors having low affinity for the drugs (Type 2 receptors) included the superficial layer of the superior colliculus, the caudate-putamen and parts of the dentate gyrus. The results of this study may help explain the physiological differences between the benzodiazepine and triazolopyridazine drugs and should point out target sites in the brain for additional studies of the apparently two different receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6257892

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Neurochemical changes associated with the action of acute administration of diazepam in reversing the behavioral paradigm conditioned emotional response (CER).

Authors:  J D Lane
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

Review 2.  Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.

Authors:  W A Colburn; M L Jack
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

3.  GABAA Receptors of Cerebellar Granule Cells in Culture: Interaction with Benzodiazepines.

Authors:  Aroldo Cupello; Mario Di Braccio; Elena Gatta; Giancarlo Grossi; Periklis Nikas; Francesca Pellistri; Mauro Robello
Journal:  Neurochem Res       Date:  2013-10-12       Impact factor: 3.996

4.  Differences in expression of GABAA receptor subunits, but not benzodiazepine binding, in the chick brainstem auditory system.

Authors:  R L Hyson; K A Sadler
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

5.  Autoradiographic localization of "peripheral-type" benzodiazepine binding sites in the rat brain, heart and kidney.

Authors:  D R Gehlert; H I Yamamura; J K Wamsley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

Review 6.  Benzodiazepine receptors resolved.

Authors:  J G Richards; P Schoch; H Möhler; W Haefely
Journal:  Experientia       Date:  1986-02-15

7.  The GABAA receptor family in the mammalian brain.

Authors:  R W Olsen; M H Bureau; S Endo; G Smith
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

Review 8.  Understanding the GABAA receptor: a chemically gated ion channel.

Authors:  F A Stephenson
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

9.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.

Authors:  Y Kiuchi; T Kobayashi; J Takeuchi; H Shimizu; H Ogata; M Toru
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

10.  Like diazepam, CL 218,872, a selective ligand for the benzodiazepine omega 1 receptor subtype, impairs place learning in the Morris water maze.

Authors:  R K McNamara; R W Skelton
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.